{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:26:32Z","timestamp":1787793992723,"version":"build-2784847793"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Health Research Foundation of Central Denmark Region","award":["A1602"],"award-info":[{"award-number":["A1602"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This explorative prospective observational pilot study investigated if suggested risk factors, rectal cancer and lung metastases, could add to a relevant detection rate of asymptomatic brain metastases (BM) from colorectal cancer (CRC). Secondary, prognostic biological aspects were investigated by translational analysis of plasma samples. The study enrolled patients with rectal cancer and lung metastases. At inclusion, patients underwent a standard MRI scan of the brain. Cell-free DNA (cfDNA) level was measured by a direct fluorescence assay (DFA), and circulating tumor DNA (ctDNA) by ddPCR. BM was detected in one of twenty-nine included patients. Patients had higher cfDNA levels than healthy subjects (p\u2009&lt;\u20090.01). Patients with the primary tumor in situ had higher cfDNA levels than those with resected primary tumor (p\u2009&lt;\u20090.01). Patients with liver involvement had higher cfDNA levels (p\u2009=\u20090.12) and circulating tumor DNA levels (p\u2009=\u20090.01) than those without liver involvement. In conclusion, the modest incidence of BM does not justify routine MRI of the brain in this selected population. cfDNA by DFA could be a valuable tool when planning treatment and follow-up for CRC patients. Future studies should focus on identifying further characteristics and biomarkers associated with a high risk of BM, enhancing the possibility for early intervention.<\/jats:p>","DOI":"10.1038\/s41598-023-45939-x","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T11:02:28Z","timestamp":1698663748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Circulating DNA and frequency of colorectal cancer brain metastases in a presumed high-risk group"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2799-1492","authenticated-orcid":false,"given":"Louise Bach","family":"Callesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Kindberg","family":"Boysen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke Fredslund","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke Beese","family":"Dalby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen-Lise Garm","family":"Spindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,30]]},"reference":[{"key":"45939_CR1","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1186\/s12885-016-2290-5","volume":"16","author":"TD Christensen","year":"2016","unstructured":"Christensen, T. D., Spindler, K.-L.G., Palshof, J. A. & Nielsen, D. L. Systematic review: Brain metastases from colorectal cancer: Incidence and patient characteristics. BMC Cancer 16, 2290 (2016).","journal-title":"BMC Cancer"},{"key":"45939_CR2","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3390\/cancers13040900","volume":"13","author":"S M\u00fcller","year":"2021","unstructured":"M\u00fcller, S. et al. Brain metastases from colorectal cancer: A systematic review of the literature and meta-analysis to establish a guideline for daily treatment. Cancers 13, 900 (2021).","journal-title":"Cancers"},{"key":"45939_CR3","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1080\/0284186X.2020.1769861","volume":"59","author":"AK Boysen","year":"2020","unstructured":"Boysen, A. K., Ording, A. G., Astradsson, A., H\u00f8yer, M. & Spindler, K.-L.G. Metastasis directed treatment of brain metastases from colorectal cancer: A Danish population-based cohort study. Acta Oncol. 59, 1118\u20131122 (2020).","journal-title":"Acta Oncol."},{"key":"45939_CR4","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1634\/theoncologist.2016-0178","volume":"22","author":"K-LG Spindler","year":"2017","unstructured":"Spindler, K.-L.G. et al. Cell-free DNA in metastatic colorectal cancer: A systematic review and meta-analysis. Oncologist 22, 1049\u20131055 (2017).","journal-title":"Oncologist"},{"key":"45939_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41416-022-01816-4","volume":"127","author":"LB Callesen","year":"2022","unstructured":"Callesen, L. B. et al. Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: A systematic review and meta-analysis. Br. J. Cancer 127, 500\u2013513 (2022).","journal-title":"Br. J. Cancer"},{"key":"45939_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cca.2018.09.029","volume":"487","author":"AK Boysen","year":"2018","unstructured":"Boysen, A. K. et al. Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancer. Clin. Chim. Acta 487, 107\u2013111 (2018).","journal-title":"Clin. Chim. Acta"},{"key":"45939_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1186\/1471-2407-13-566","volume":"13","author":"JP Roperch","year":"2013","unstructured":"Roperch, J. P. et al. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer. BMC Cancer 13, 566 (2013).","journal-title":"BMC Cancer"},{"key":"45939_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cca.2015.04.015","volume":"446","author":"N Pallisgaard","year":"2015","unstructured":"Pallisgaard, N. et al. Controls to validate plasma samples for cell free DNA quantification. Clin. Chim. Acta 446, 141\u2013146 (2015).","journal-title":"Clin. Chim. Acta"},{"key":"45939_CR9","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.3390\/cancers13102451","volume":"13","author":"AC Lef\u00e8vre","year":"2021","unstructured":"Lef\u00e8vre, A. C. et al. The clinical value of measuring circulating hpv dna during chemo-radiotherapy in squamous cell carcinoma of the anus. Cancers 13, 2451 (2021).","journal-title":"Cancers"},{"key":"45939_CR10","first-page":"1","volume":"12","author":"Q Chen","year":"2022","unstructured":"Chen, Q. et al. Risk factors on the incidence and prognostic effects of colorectal cancer with brain metastasis: A SEER-based study. Front. Oncol. 12, 1\u201311 (2022).","journal-title":"Front. Oncol."},{"key":"45939_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejca.2022.12.019","volume":"181","author":"PC Chen","year":"2023","unstructured":"Chen, P. C. et al. HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching study. Eur. J. Cancer 181, 62\u201369 (2023).","journal-title":"Eur. J. Cancer"},{"key":"45939_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/17588359221133171","volume":"14","author":"LB Callesen","year":"2022","unstructured":"Callesen, L. B. et al. Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: A systematic review and meta-analysis. Ther. Adv. Med. Oncol. 14, 1\u201318 (2022).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"45939_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/17588359231156393","volume":"15","author":"K-LG Spindler","year":"2023","unstructured":"Spindler, K.-L.G., Callesen, L. B. & Arnold, D. Time for a lead-time definition? Author response to \u2018Why the length of recurrence free survival or \u201clead-times\u201d can be misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et al. Circulating DNA in patients undergoing loco-regional treatment of co. Ther. Adv. Med. Oncol. 15, 1\u20134 (2023).","journal-title":"Ther. Adv. Med. Oncol."},{"key":"45939_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00162","volume":"3","author":"CB Thomsen","year":"2019","unstructured":"Thomsen, C. B. et al. Correlation between tumor-specific mutated and methylated DNA in colorectal cancer. JCO Precis. Oncol. 3, 1\u20138 (2019).","journal-title":"JCO Precis. Oncol."},{"key":"45939_CR15","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/ijc.33672","volume":"149","author":"J Hamfjord","year":"2021","unstructured":"Hamfjord, J. et al. Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancer. Int. J. Cancer 149, 1385\u20131397 (2021).","journal-title":"Int. J. Cancer"},{"key":"45939_CR16","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s41416-019-0457-y","volume":"120","author":"H Bando","year":"2019","unstructured":"Bando, H. et al. A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer. Br. J. Cancer 120, 982\u2013986 (2019).","journal-title":"Br. J. Cancer"},{"key":"45939_CR17","first-page":"1","volume":"6","author":"H Bando","year":"2022","unstructured":"Bando, H. et al. Effects of metastatic sites on circulating tumor DNA in patients with metastatic colorectal cancer. JCO Precis. Oncol. 6, 1\u201315 (2022).","journal-title":"JCO Precis. Oncol."},{"key":"45939_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/0284186X.2016.1253861","volume":"56","author":"K-LG Spindler","year":"2017","unstructured":"Spindler, K.-L.G. Methodological, biological and clinical aspects of circulating free DNA in metastatic colorectal cancer. Acta Oncol. 56, 7\u201316 (2017).","journal-title":"Acta Oncol."},{"key":"45939_CR19","first-page":"646","volume":"37","author":"SA Leon","year":"1977","unstructured":"Leon, S. A., Shapiro, B., Sklaroff, D. M. & Yaros, M. J. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 37, 646\u2013650 (1977).","journal-title":"Cancer Res."},{"key":"45939_CR20","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1002\/ijc.28946","volume":"135","author":"K-LG Spindler","year":"2014","unstructured":"Spindler, K.-L.G. et al. Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer. Int. J. Cancer 135, 2984\u20132991 (2014).","journal-title":"Int. J. Cancer"},{"key":"45939_CR21","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1016\/j.ejca.2015.06.118","volume":"51","author":"K-LG Spindler","year":"2015","unstructured":"Spindler, K.-L.G. et al. Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor therapy. Eur. J. Cancer 51, 2678\u20132685 (2015).","journal-title":"Eur. J. Cancer"},{"key":"45939_CR22","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/annonc\/mdz139","volume":"30","author":"J Hamfjord","year":"2019","unstructured":"Hamfjord, J. et al. Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy. Ann. Oncol. 30, 1088\u20131095 (2019).","journal-title":"Ann. Oncol."},{"key":"45939_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mco.2022.2497","volume":"16","author":"LB Callesen","year":"2022","unstructured":"Callesen, L. B. et al. Total cell-free DNA measurement in metastatic colorectal cancer with a fast and easy direct fluorescent assay. Mol. Clin. Oncol. 16, 1\u20139 (2022).","journal-title":"Mol. Clin. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45939-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45939-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45939-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T22:48:54Z","timestamp":1703458134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45939-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["45939"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-45939-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,30]]},"assertion":[{"value":"12 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18574"}}